Latest News and Press Releases
Want to stay updated on the latest news?
-
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
-
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
-
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
-
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
-
PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis
-
Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus
-
Lipella Pharmaceuticals to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New York
-
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research
-
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
-
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial